• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

辛二酰苯胺异羟肟酸通过抑制硫氧还蛋白相关蛋白14介导的自噬使神经母细胞瘤对紫杉醇敏感。

Suberoylanilide hydroxamic acid sensitizes neuroblastoma to paclitaxel by inhibiting thioredoxin-related protein 14-mediated autophagy.

作者信息

Zhen Zijun, Yang Kaibin, Ye Litong, You Zhiyao, Chen Rirong, Liu Ying, He Youjian

机构信息

State Key Laboratory of Oncology in South China, Guangzhou, China.

Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.

出版信息

Cancer Sci. 2017 Jul;108(7):1485-1492. doi: 10.1111/cas.13279. Epub 2017 Jun 19.

DOI:10.1111/cas.13279
PMID:28498513
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5497723/
Abstract

Paclitaxel is not as effective for neuroblastoma as most of the front-line chemotherapeutics due to drug resistance. This study explored the regulatory mechanism of paclitaxel-associated autophagy and potential solutions to paclitaxel resistance in neuroblastoma. The formation of autophagic vesicles was detected by scanning transmission electron microscopy and flow cytometry. The autophagy-associated proteins were assessed by western blot. Autophagy was induced and the autophagy-associated proteins LC3-I, LC3-II, Beclin 1, and thioredoxin-related protein 14 (TRP14), were found to be upregulated in neuroblastoma cells that were exposed to paclitaxel. The inhibition of Beclin 1 or TRP14 by siRNA increased the sensitivity of the tumor cells to paclitaxel. In addition, Beclin 1-mediated autophagy was regulated by TRP14. Furthermore, the TRP14 inhibitor suberoylanilide hydroxamic acid (SAHA) downregulated paclitaxel-induced autophagy and enhanced the anticancer effects of paclitaxel in normal control cancer cells but not in cells with upregulated Beclin 1 and TRP14 expression. Our findings showed that paclitaxel-induced autophagy in neuroblastoma cells was regulated by TRP14 and that SAHA could sensitize neuroblastoma cells to paclitaxel by specifically inhibiting TRP14.

摘要

由于耐药性,紫杉醇对神经母细胞瘤的疗效不如大多数一线化疗药物。本研究探讨了紫杉醇相关自噬的调控机制以及神经母细胞瘤中紫杉醇耐药的潜在解决方案。通过扫描透射电子显微镜和流式细胞术检测自噬小泡的形成。通过蛋白质免疫印迹法评估自噬相关蛋白。诱导自噬后,发现暴露于紫杉醇的神经母细胞瘤细胞中自噬相关蛋白LC3-I、LC3-II、Beclin 1和硫氧还蛋白相关蛋白14(TRP14)上调。用小干扰RNA(siRNA)抑制Beclin 1或TRP14可增加肿瘤细胞对紫杉醇的敏感性。此外,Beclin 1介导的自噬受TRP14调控。此外,TRP14抑制剂辛二酰苯胺异羟肟酸(SAHA)下调了紫杉醇诱导的自噬,并增强了紫杉醇对正常对照癌细胞的抗癌作用,但对Beclin 1和TRP14表达上调的细胞无效。我们的研究结果表明,神经母细胞瘤细胞中紫杉醇诱导的自噬受TRP14调控,SAHA可通过特异性抑制TRP14使神经母细胞瘤细胞对紫杉醇敏感。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0386/5497723/2482b4ea3da5/CAS-108-1485-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0386/5497723/9ac6bc2606bb/CAS-108-1485-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0386/5497723/9e5d480c0b4a/CAS-108-1485-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0386/5497723/32d1c35eb5c7/CAS-108-1485-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0386/5497723/eb5c38c25350/CAS-108-1485-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0386/5497723/2482b4ea3da5/CAS-108-1485-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0386/5497723/9ac6bc2606bb/CAS-108-1485-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0386/5497723/9e5d480c0b4a/CAS-108-1485-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0386/5497723/32d1c35eb5c7/CAS-108-1485-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0386/5497723/eb5c38c25350/CAS-108-1485-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0386/5497723/2482b4ea3da5/CAS-108-1485-g005.jpg

相似文献

1
Suberoylanilide hydroxamic acid sensitizes neuroblastoma to paclitaxel by inhibiting thioredoxin-related protein 14-mediated autophagy.辛二酰苯胺异羟肟酸通过抑制硫氧还蛋白相关蛋白14介导的自噬使神经母细胞瘤对紫杉醇敏感。
Cancer Sci. 2017 Jul;108(7):1485-1492. doi: 10.1111/cas.13279. Epub 2017 Jun 19.
2
TXNDC17 promotes paclitaxel resistance via inducing autophagy in ovarian cancer.TXNDC17通过诱导卵巢癌自噬促进对紫杉醇的耐药性。
Autophagy. 2015;11(2):225-38. doi: 10.1080/15548627.2014.998931.
3
Autophagy induced by suberoylanilide hydroxamic acid in Hela S3 cells involves inhibition of protein kinase B and up-regulation of Beclin 1.辛二酰苯胺异羟肟酸诱导Hela S3细胞自噬涉及抑制蛋白激酶B和上调Beclin 1。
Int J Biochem Cell Biol. 2008;40(2):272-83. doi: 10.1016/j.biocel.2007.07.020. Epub 2007 Aug 10.
4
Mechanism of Drug Resistance to First-Line Chemotherapeutics Mediated by TXNDC17 in Neuroblastomas.TXNDC17 介导的神经母细胞瘤一线化疗药物耐药的机制。
Cancer Rep (Hoboken). 2024 Oct;7(10):e70033. doi: 10.1002/cnr2.70033.
5
The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer.组蛋白去乙酰化酶抑制剂 SAHA 诱导乳腺癌细胞生长抑制,并增强紫杉醇诱导的细胞死亡。
Cancer Chemother Pharmacol. 2010 Nov;66(6):1131-40. doi: 10.1007/s00280-010-1455-1. Epub 2010 Sep 14.
6
Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patients.伏立诺他(SAHA)与紫杉醇对卵巢癌细胞系及患者原发性卵巢癌细胞治疗效果的比较评估。
BMC Cancer. 2006 Jul 11;6:183. doi: 10.1186/1471-2407-6-183.
7
Effects of suberoylanilide hydroxamic acid (SAHA) combined with paclitaxel (PTX) on paclitaxel-resistant ovarian cancer cells and insights into the underlying mechanisms.亚油酸酰苯胺羟肟酸(SAHA)联合紫杉醇(PTX)对紫杉醇耐药卵巢癌细胞的影响及作用机制探讨。
Cancer Cell Int. 2014 Nov 26;14(1):112. doi: 10.1186/s12935-014-0112-x. eCollection 2014.
8
Knockdown of galectin-1 facilitated cisplatin sensitivity by inhibiting autophagy in neuroblastoma cells.敲低半乳糖凝集素-1 通过抑制自噬增强神经母细胞瘤细胞对顺铂的敏感性。
Chem Biol Interact. 2019 Jan 5;297:50-56. doi: 10.1016/j.cbi.2018.10.014. Epub 2018 Oct 23.
9
SAHA regulates histone acetylation, Butyrylation, and protein expression in neuroblastoma.SAHA调节神经母细胞瘤中的组蛋白乙酰化、丁酰化和蛋白质表达。
J Proteome Res. 2014 Oct 3;13(10):4211-9. doi: 10.1021/pr500497e. Epub 2014 Sep 22.
10
The combination of irreversible EGFR TKIs and SAHA induces apoptosis and autophagy-mediated cell death to overcome acquired resistance in EGFR T790M-mutated lung cancer.不可逆表皮生长因子受体酪氨酸激酶抑制剂(EGFR TKIs)与伏立诺他联合使用可诱导细胞凋亡和自噬介导的细胞死亡,以克服EGFR T790M突变型肺癌中的获得性耐药。
Int J Cancer. 2015 Jun 1;136(11):2717-29. doi: 10.1002/ijc.29320. Epub 2014 Nov 26.

引用本文的文献

1
Mechanism of Drug Resistance to First-Line Chemotherapeutics Mediated by TXNDC17 in Neuroblastomas.TXNDC17 介导的神经母细胞瘤一线化疗药物耐药的机制。
Cancer Rep (Hoboken). 2024 Oct;7(10):e70033. doi: 10.1002/cnr2.70033.
2
Therapy resistance in neuroblastoma: Mechanisms and reversal strategies.神经母细胞瘤中的治疗抵抗:机制与逆转策略。
Front Pharmacol. 2023 Feb 16;14:1114295. doi: 10.3389/fphar.2023.1114295. eCollection 2023.
3
Investigation of chemoresistance to first-line chemotherapy and its possible association with autophagy in high-risk neuroblastoma.

本文引用的文献

1
Autophagy is associated with chemoresistance in neuroblastoma.自噬与神经母细胞瘤的化疗耐药相关。
BMC Cancer. 2016 Nov 15;16(1):891. doi: 10.1186/s12885-016-2906-9.
2
Carboplatin plus Weekly Paclitaxel with Bevacizumab for First-line Treatment of Non-small Cell Lung Cancer.卡铂联合每周一次紫杉醇及贝伐单抗用于非小细胞肺癌的一线治疗
Anticancer Res. 2016 Jan;36(1):307-12.
3
Pilot trial of paclitaxel-trastuzumab adjuvant therapy for early stage breast cancer: a trial of the ECOG-ACRIN cancer research group (E2198).紫杉醇-曲妥珠单抗辅助治疗早期乳腺癌的试点试验:东部肿瘤协作组-美国放射肿瘤学会癌症研究组(E2198)的一项试验
高危神经母细胞瘤对一线化疗的化疗耐药性及其与自噬的可能关联的研究。
Front Oncol. 2022 Oct 20;12:1019106. doi: 10.3389/fonc.2022.1019106. eCollection 2022.
4
Vorinostat in autophagic cell death: A critical insight into autophagy-mediated, -associated and -dependent cell death for cancer prevention.伏立诺他在自噬细胞死亡中的作用:对自噬介导线粒体依赖性细胞死亡的深入了解及其在癌症预防中的应用。
Drug Discov Today. 2022 Jan;27(1):269-279. doi: 10.1016/j.drudis.2021.08.004. Epub 2021 Aug 13.
5
Personalized Medicine for Neuroblastoma: Moving from Static Genotypes to Dynamic Simulations of Drug Response.神经母细胞瘤的个性化医学:从静态基因型转向药物反应的动态模拟
J Pers Med. 2021 May 11;11(5):395. doi: 10.3390/jpm11050395.
6
Targeting Cytoprotective Autophagy to Enhance Anticancer Therapies.靶向细胞保护性自噬以增强抗癌疗法
Front Oncol. 2021 Feb 25;11:626309. doi: 10.3389/fonc.2021.626309. eCollection 2021.
7
Changes in the Expression of TBP-2 in Response to Histone Deacetylase Inhibitor Treatment in Human Endometrial Cells.TBP-2 表达在人子宫内膜细胞中对组蛋白去乙酰化酶抑制剂治疗的反应变化。
Int J Mol Sci. 2021 Jan 31;22(3):1427. doi: 10.3390/ijms22031427.
8
Neuroblastoma and the epigenome.神经母细胞瘤与表观基因组。
Cancer Metastasis Rev. 2021 Mar;40(1):173-189. doi: 10.1007/s10555-020-09946-y. Epub 2021 Jan 6.
9
HM30181A, a potent P-glycoprotein inhibitor, potentiates the absorption and antitumor efficacy of paclitaxel in an orthotopic brain tumor model.HM30181A,一种有效的 P-糖蛋白抑制剂,可增强紫杉醇在原位脑肿瘤模型中的吸收和抗肿瘤疗效。
Cancer Biol Med. 2020 Nov 15;17(4):986-1001. doi: 10.20892/j.issn.2095-3941.2020.0128. Epub 2020 Dec 15.
10
Molecular Mechanisms Underlying Autophagy-Mediated Treatment Resistance in Cancer.癌症中自噬介导的治疗耐药性的分子机制
Cancers (Basel). 2019 Nov 11;11(11):1775. doi: 10.3390/cancers11111775.
Br J Cancer. 2015 Dec 22;113(12):1651-7. doi: 10.1038/bjc.2015.405. Epub 2015 Dec 1.
4
Synergistic anticancer effects of cisplatin and histone deacetylase inhibitors (SAHA and TSA) on cholangiocarcinoma cell lines.顺铂与组蛋白去乙酰化酶抑制剂(SAHA 和 TSA)联合对胆管癌细胞系的协同抗癌作用。
Int J Oncol. 2016 Jan;48(1):409-20. doi: 10.3892/ijo.2015.3240. Epub 2015 Nov 9.
5
Randomized, Double-Blind Phase II Trial With Prospective Classification by ATM Protein Level to Evaluate the Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients With Recurrent or Metastatic Gastric Cancer.随机、双盲 II 期临床试验,前瞻性按 ATM 蛋白水平分类,以评估奥拉帕利联合紫杉醇治疗复发性或转移性胃癌患者的疗效和耐受性。
J Clin Oncol. 2015 Nov 20;33(33):3858-65. doi: 10.1200/JCO.2014.60.0320. Epub 2015 Aug 17.
6
KLF4-SQSTM1/p62-associated prosurvival autophagy contributes to carfilzomib resistance in multiple myeloma models.KLF4-SQSTM1/p62相关的促生存自噬在多发性骨髓瘤模型中导致卡非佐米耐药。
Oncotarget. 2015 Jun 20;6(17):14814-31. doi: 10.18632/oncotarget.4530.
7
Exploiting the potential of autophagy in cisplatin therapy: A new strategy to overcome resistance.挖掘自噬在顺铂治疗中的潜力:一种克服耐药性的新策略。
Oncotarget. 2015 Jun 20;6(17):15551-65. doi: 10.18632/oncotarget.3902.
8
Proteomics analysis of human oligodendroglioma proteome.人类少突胶质细胞瘤蛋白质组的蛋白质组学分析。
Gene. 2015 Sep 10;569(1):77-82. doi: 10.1016/j.gene.2015.05.039. Epub 2015 May 19.
9
Chemoresistance is associated with increased cytoprotective autophagy and diminished apoptosis in bladder cancer cells treated with the BH3 mimetic (-)-Gossypol (AT-101).在用BH3模拟物(-)-棉子酚(AT-101)处理的膀胱癌细胞中,化疗耐药性与细胞保护性自噬增加和细胞凋亡减少有关。
BMC Cancer. 2015 Apr 7;15:224. doi: 10.1186/s12885-015-1239-4.
10
Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastoma.实施分子导向疗法治疗复发或难治性神经母细胞瘤患者的可行性。
Cancer Med. 2015 Jun;4(6):871-86. doi: 10.1002/cam4.436. Epub 2015 Feb 26.